They discovered that the levels of phosphorylated ERK was significantly upregulated in U87MG and T98G cells treated with miltefosine, and activated ERK increased FADD expression, resulting in enhancement of glioma cell apoptosis induced by miltefosine. This evidence concerns the gene FADD and central nervous system cancer.